Table 2

Comorbidities, symptoms, and healthcare use of participants in the development sample

 Controls (n=28 296)Cases (n=15 159)Unadjusted OR(95% CI)
 N(%)N(%)
Comorbidities*
 Asthma24388.6566937.46.61(6.23 to 7.02)
 Ischaemic heart disease557219.7356023.51.31(1.25 to 1.38)
 Heart failure6872.48475.62.50(2.24 to 2.77)
 Stroke8503.05393.61.23(1.10 to 1.37)
 Hyperlipidaemia332711.8166011.00.93(0.87 to 1.00)
 Anaemia15545.58595.71.04(0.95 to 1.14)
 Pulmonary embolism500.2710.52.72(1.89 to 3.91)
 Deep vein thrombosis1390.51070.71.44(1.12 to 1.86)
 Atrial fibrillation9803.56904.61.37(1.24 to 1.51)
 Lung cancer350.1680.43.68(2.45 to 5.55)
 Cancer380513.4209813.81.05(0.99 to 1.11)
 Depression†9673.46304.21.24(1.12 to 1.38)
 Anxiety†20567.3181612.01.77(1.65 to 1.90)
 Allergic rhinitis19176.811527.61.13(1.05 to 1.22)
 Tuberculosis4211.53652.41.66(1.44 to 1.91)
 Pulmonary tuberculosis3711.33442.31.77(1.52 to 2.06)
 Chronic kidney disease560.2450.31.69(1.11 to 2.60)
 Helicobacter pylori1880.71390.91.45(1.16 to 1.81)
 Gastric ulcer5451.94723.11.63(1.43 to 1.85)
 Gastooesophageal reflux disease18976.712298.11.25(1.16 to 1.35)
 Osteoporosis7132.55693.81.58(1.41 to 1.78)
 Fractures386213.6254716.81.30(1.23 to 1.38)
 Diabetes21677.710156.70.87(0.81 to 0.94)
 Rheumatoid arthritis4621.63692.41.52(1.32 to 1.75)
 Lower respiratory tract infections†
  025 12888.8934461.61
  122057.8294719.44.02(3.76 to 4.29)
  >19633.4286818.99.76(8.93 to 10.66)
 Upper respiratory tract infections†
  022 35579.010 62370.11
  1391713.8270217.81.47(1.39 to 1.56)
  >120247.2183412.11.98(1.85 to 2.13)
 Allergy761426.9504533.31.40(1.34 to 1.46)
Symptoms†
 Presentations with cough
  023 47082.9818054.01
  1307210.9313020.63.14(2.96 to 3.34)
  >117546.2384925.47.12(6.64 to 7.63)
 Presentations with dyspnoea
  026 78994.711 29474.51
  110143.6222014.65.57(5.12 to 6.06)
  >14931.7164510.99.01(8.05 to 10.09)
 Wheeze4561.6186012.38.89(7.96 to 9.94)
 Sputum production2450.96094.05.32(4.52 to 6.26)
 Weight loss2110.73062.02.74(2.30 to 3.28)
 Fatigue15505.512158.01.53(1.42 to 1.66)
 Poor sleep9773.58105.31.59(1.44 to 1,75)
Health service use†‡
 Antibiotic courses
  018 79966.4515034.01
  1536118.9331321.92.34(2.21 to 2.47)
  221277.5226715.04.04(3.76 to 4.34)
  >220097.1442929.28.64(8.07 to 9.25)
 Salbutamol24928.8772350.911.5(10.8 to 12.2)
 Prednisolone18006.4435828.76.17(5.78 to 6.58)
GP consultations
  <5516218.211567.61
  5–10461816.3173411.41.81(1.66 to 1.98)
  10–20767727.1374524.72.55(2.36 to 2.77)
  20–40761026.9513633.93.99(3.68 to 4.32)
  >40322911.4338822.36.91(6.31 to 7.57)
 Hospital referrals7032.56874.52.08(1.85 to 2.34)
  • Unadjusted OR for association with COPD.

  • *Ever previously diagnosed.

  • †Within 3 years of COPD diagnosis or equivalent matched time point for controls.

  • COPD, chronic obstructive pulmonary disease; GP, general practitioner.